Patents by Inventor Shaowei ONG

Shaowei ONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
    Publication number: 20240131035
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Application
    Filed: October 27, 2023
    Publication date: April 25, 2024
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming CHEN, Shaowei ONG
  • Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol
    Patent number: 11857555
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: January 2, 2024
    Assignee: ANTARES PHARMA, INC.
    Inventors: Xiaoming Chen, Shaowei Ong
  • AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
    Publication number: 20230302016
    Abstract: The present disclosure provides aqueous formulations comprising hydrocortisone sodium phosphate and monothioglycerol. In some embodiments, the formulations comprise monobasic sodium phosphate, dibasic sodium phosphate, or disodium EDTA. The present disclosure further provides a method of treating a disease or disorder in a subject by administering the aqueous formulation.
    Type: Application
    Filed: March 24, 2023
    Publication date: September 28, 2023
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming Chen, Shaowei ONG
  • AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
    Publication number: 20230099165
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Application
    Filed: November 18, 2022
    Publication date: March 30, 2023
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming CHEN, Shaowei ONG
  • AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
    Publication number: 20220096496
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Application
    Filed: October 5, 2021
    Publication date: March 31, 2022
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming CHEN, Shaowei ONG
  • Testosterone Ester Triglyceride Formulations
    Publication number: 20220079955
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Application
    Filed: August 18, 2021
    Publication date: March 17, 2022
    Applicant: Antares Pharma, Inc.
    Inventor: Shaowei Ong
  • Testosterone ester triglyceride formulations
    Patent number: 11123352
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: September 21, 2021
    Assignee: Antares Pharma, Inc.
    Inventor: Shaowei Ong
  • Testosterone Ester Triglyceride Formulations
    Publication number: 20200289528
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Application
    Filed: April 13, 2020
    Publication date: September 17, 2020
    Applicant: Antares Pharma, Inc.
    Inventor: Shaowei Ong
  • Testosterone ester triglyceride formulations
    Patent number: 10646495
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: May 12, 2020
    Assignee: Antares Pharma, Inc.
    Inventor: Shaowei Ong
  • TESTOSTERONE ESTER TRIGLYCERIDE FORMULATIONS
    Publication number: 20190060326
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Application
    Filed: August 30, 2018
    Publication date: February 28, 2019
    Inventor: Shaowei ONG